Surprisingly high prevalence of anxiety and depression in chronic breathing disorders

Research output: Contribution to journalArticle

Mark E. Kunik, Kent Roundy, Connie Veazey, Julianne Souchek, Peter Richardson, Nelda Wray, Melinda A. Stanley

Study objectives: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD. Design: Cross-sectional study. Setting: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC). Participants: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC. Measurements: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). Results: Of patients screened with the PRIME-MD, 80% screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80%. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65% received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31% were receiving treatment for depression and/or anxiety. Conclusions: It is troubling that a mere 31% of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study.

Original languageEnglish (US)
Pages (from-to)1205-1211
Number of pages7
JournalCHEST
Volume127
Issue number4
DOIs
StatePublished - Jan 1 2005

PMID: 15821196

Altmetrics

Cite this

Standard

Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. / Kunik, Mark E.; Roundy, Kent; Veazey, Connie; Souchek, Julianne; Richardson, Peter; Wray, Nelda; Stanley, Melinda A.

In: CHEST, Vol. 127, No. 4, 01.01.2005, p. 1205-1211.

Research output: Contribution to journalArticle

Harvard

Kunik, ME, Roundy, K, Veazey, C, Souchek, J, Richardson, P, Wray, N & Stanley, MA 2005, 'Surprisingly high prevalence of anxiety and depression in chronic breathing disorders' CHEST, vol. 127, no. 4, pp. 1205-1211. https://doi.org/10.1378/chest.127.4.1205

APA

Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N., & Stanley, M. A. (2005). Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. CHEST, 127(4), 1205-1211. https://doi.org/10.1378/chest.127.4.1205

Vancouver

Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray N et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. CHEST. 2005 Jan 1;127(4):1205-1211. https://doi.org/10.1378/chest.127.4.1205

Author

Kunik, Mark E. ; Roundy, Kent ; Veazey, Connie ; Souchek, Julianne ; Richardson, Peter ; Wray, Nelda ; Stanley, Melinda A. / Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. In: CHEST. 2005 ; Vol. 127, No. 4. pp. 1205-1211.

BibTeX

@article{d9ff71ded70b40aeb1159e32cc1e3a61,
title = "Surprisingly high prevalence of anxiety and depression in chronic breathing disorders",
abstract = "Study objectives: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD. Design: Cross-sectional study. Setting: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC). Participants: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC. Measurements: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). Results: Of patients screened with the PRIME-MD, 80{\%} screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80{\%}. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65{\%} received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31{\%} were receiving treatment for depression and/or anxiety. Conclusions: It is troubling that a mere 31{\%} of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study.",
keywords = "Anxiety, Anxiety disorders, Chronic obstructive, Depression, Depressive disorder, Lung diseases, Obstructive, Prevalence, Pulmonary disease",
author = "Kunik, {Mark E.} and Kent Roundy and Connie Veazey and Julianne Souchek and Peter Richardson and Nelda Wray and Stanley, {Melinda A.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1378/chest.127.4.1205",
language = "English (US)",
volume = "127",
pages = "1205--1211",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

RIS

TY - JOUR

T1 - Surprisingly high prevalence of anxiety and depression in chronic breathing disorders

AU - Kunik, Mark E.

AU - Roundy, Kent

AU - Veazey, Connie

AU - Souchek, Julianne

AU - Richardson, Peter

AU - Wray, Nelda

AU - Stanley, Melinda A.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Study objectives: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD. Design: Cross-sectional study. Setting: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC). Participants: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC. Measurements: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). Results: Of patients screened with the PRIME-MD, 80% screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80%. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65% received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31% were receiving treatment for depression and/or anxiety. Conclusions: It is troubling that a mere 31% of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study.

AB - Study objectives: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD. Design: Cross-sectional study. Setting: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC). Participants: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC. Measurements: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). Results: Of patients screened with the PRIME-MD, 80% screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80%. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65% received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31% were receiving treatment for depression and/or anxiety. Conclusions: It is troubling that a mere 31% of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study.

KW - Anxiety

KW - Anxiety disorders

KW - Chronic obstructive

KW - Depression

KW - Depressive disorder

KW - Lung diseases

KW - Obstructive

KW - Prevalence

KW - Pulmonary disease

UR - http://www.scopus.com/inward/record.url?scp=19044376762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19044376762&partnerID=8YFLogxK

U2 - 10.1378/chest.127.4.1205

DO - 10.1378/chest.127.4.1205

M3 - Article

VL - 127

SP - 1205

EP - 1211

JO - Chest

T2 - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -

ID: 3310406